JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹195 Cr | ₹164 Cr | ₹141 Cr | ₹143 Cr | ₹120 Cr |
What is the latest Total Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹195 Cr |
| Mar2024 | ₹164 Cr |
| Mar2023 | ₹141 Cr |
| Mar2022 | ₹143 Cr |
| Mar2021 | ₹120 Cr |
How is Total Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹195 Cr | 18.51 | |
| Mar2024 | ₹164 Cr | 16.21 | |
| Mar2023 | ₹141 Cr | -0.84 | |
| Mar2022 | ₹143 Cr | 18.38 | |
| Mar2021 | ₹120 Cr | - | |
Compare Total Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹448.3 Cr | 1.9% | -4.2% | 4.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 1.9% |
-4.2% |
4.3% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses